❌

Reading view

Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment

arXiv:2603.21597v2 Announce Type: replace Abstract: Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in multimodal foundation models have improved performance on various clinical tasks, most existing models remain static, opaque, and poorly aligned with real-world clinical workflows. We present Cerebra, an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis. These outputs are synthesized into a clinician-facing dashboard that combines visual analytics with a conversational interface, enabling clinicians to interrogate predictions and contextualize risk at the point of care. Cerebra supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete. We evaluated Cerebra using a massive multi-institutional dataset spanning 3 million patients from four independent healthcare systems. Cerebra consistently outperformed both state-of-the-art single-modality models and large multimodal language model baselines. In dementia risk prediction, it achieved AUROCs up to 0.80, compared with 0.74 for the strongest single-modality model and 0.68 for language model baselines. For dementia diagnosis, it achieved an AUROC of 0.86, and for survival prediction, a C-index of 0.81. In a reader study with experienced physicians, Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation. These results demonstrate Cerebra's potential for interpretable, robust decision support in clinical care.
  •  

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-w

A clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.
  •  

Non-Invasive Reconstruction of Intracranial EEG Across the Deep Temporal Lobe from Scalp EEG based on Conditional Normalizing Flow

arXiv:2603.03354v1 Announce Type: new Abstract: Although obtaining deep brain activity from non-invasive scalp electroencephalography (sEEG) is crucial for neuroscience and clinical diagnosis, directly generating high-fidelity intracranial electroencephalography (iEEG) signals remains a largely unexplored field, limiting our understanding of deep brain dynamics. Current research primarily focuses on traditional signal processing or source localization methods, which struggle to capture the complex waveforms and random characteristics of iEEG. To address this critical challenge, this paper introduces NeuroFlowNet, a novel cross-modal generative framework whose core contribution lies in the first-ever reconstruction of iEEG signals from the entire deep temporal lobe region using sEEG signals. NeuroFlowNet is built on Conditional Normalizing Flow (CNF), which directly models complex conditional probability distributions through reversible transformations, thereby explicitly capturing the randomness of brain signals and fundamentally avoiding the pattern collapse issues common in existing generative models. Additionally, the model integrates a multi-scale architecture and self-attention mechanisms to robustly capture fine-grained temporal details and long-range dependencies. Validation results on a publicly available synchronized sEEG-iEEG dataset demonstrate NeuroFlowNet's effectiveness in terms of temporal waveform fidelity, spectral feature reproduction, and functional connectivity restoration. This study establishes a more reliable and scalable new paradigm for non-invasive analysis of deep brain dynamics. The code of this study is available in https://github.com/hdy6438/NeuroFlowNet
  •  
❌